At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 157 enrolled
Drug / intervention
MEDI8111 +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase I, Single-blind, Randomised, Placebo-controlled, Single Centre Study to Investigate the Safety, Tolerability and Pharmacodynamics of Intravenous MEDI8111 After Single Ascending Doses in Healthy Male Subjects
In Brief
A Phase 1 clinical trial evaluating MEDI8111 and Placebo for Healthy Subjects. Completed, enrolled 157 participants across 1 site.
Detailed Summary
A study to investigate the safety, tolerability and pharmacodynamics of MEDI8111 after single ascending doses in healthy male.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy Subjects
CountriesUnited Kingdom
Collaborators--
Timeline
Phase 1CompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedOct 2013
Enrollment StartNov 2013
Primary CompletionOct 2014
TodayJul 2026
First PostedOct 9, 2013
Enrollment StartNov 1, 2013
Primary CompletionOct 1, 2014
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 12.7 years ago
Interventions
MEDI8111drug
MEDI8111 lyophilisate for solution for infusion
Placeboother
Placebo for MEDI8111 saline solution for infusion